Topics

Glioblastoma | Treatment | Targeted therapy | Depatuxizumab mafodotin

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Depatuxizumab mafodotin

Moghib K, Hassan MA, Eljadid GY, Salomon I, Algazar MA, Abu Arafeh MW, Baklola M, Hafez W, Ibrahim IA.
Safety and efficacy of depatuxizumab mafodotin monotherapy or in combination with temozolomide in patients with/without EGFR-amplified recurrent glioblastoma: a systematic review.
Ann Med Surg (Lond). 2025 Sep 17;87(11):7478-7494. doi: 10.1097/MS9.0000000000003869. PMID: 41180763. Review. ˍ